Anticoagulation therapy in COVID-19 patients with chronic kidney disease

Anticoagulation therapy in COVID-19 patients with chronic kidney disease

Coagulopathy and derangements in the coagulation parameters are significant features of COVID-19 infection, which increases the risk of disseminated intravascular coagulation, thrombosis, and hemorrhage in these patients, resulting in increased morbidity and mortality. In times of COVID-19, special...

Full description

Bibliographic Details
Main Authors: Mohammad Ali Shafiee, Sayyideh Forough Hosseini, Mojgan Mortazavi, Anahita Emami, Mahtab Mojtahed Zadeh, Sanaz Moradi, Pouyan Shaker
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Journal of Research in Medical Sciences
Subjects:
anticoagulation therapy
chronic kidney disease
coagulation system
covid-19
d-dimer
Online Access:http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2021;volume=26;issue=1;spage=63;epage=63;aulast=Shafiee

Internet

http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2021;volume=26;issue=1;spage=63;epage=63;aulast=Shafiee

Similar Items